Targeting post-translational modification of transcription factors as cancer therapy
- 1 August 2020
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 25 (8) , 1502-1512
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81830107, 81973349, LR19H310002)
- Natural Science Foundation of Zhejiang Province (81830107, 81973349, LR19H310002)
This publication has 65 references indexed in Scilit:
- Acetylation of Snail Modulates the Cytokinome of Cancer Cells to Enhance the Recruitment of MacrophagesCancer Cell, 2014
- The pyrido[b]indole MDM2 inhibitor SP-141 exerts potent therapeutic effects in breast cancer modelsNature Communications, 2014
- Regulation of transcription factor activity by interconnected post-translational modificationsTrends in Pharmacological Sciences, 2014
- Lenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma CellsScience, 2014
- Nutlin-3 inhibits epithelial–mesenchymal transition by interfering with canonical transforming growth factor-β1-Smad-Snail/Slug axisCancer Letters, 2014
- Transcriptional regulation by the Set7 lysine methyltransferaseEpigenetics, 2013
- Context-specific regulation of cancer epigenomes by histone and transcription factor methylationOncogene, 2013
- A SUMOylation-Dependent Transcriptional Subprogram Is Required for Myc-Driven TumorigenesisScience, 2012
- The Drug-Induced Degradation of Oncoproteins: An Unexpected Achilles' Heel of Cancer Cells?Cancer Discovery, 2011
- The impact of acetylation and deacetylation on the p53 pathwayProtein & Cell, 2011